Literature DB >> 23299646

Pretransplantation pharmacokinetic assessments to predict posttransplantation dosing requirements in renal transplant recipients: what is known?

E van Maarseveen, A D van Zuilen.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23299646     DOI： 10.1038/clpt.2012.214

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  2 in total

1.  Kuypers and Vanhove reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker.

Authors:  Dirk R J Kuypers; Thomas Vanhove
Journal:  Br J Clin Pharmacol       Date:  2018-04-24       Impact factor: 4.335

Review 2.  Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.

Authors:  Jeannine S McCune; Meagan J Bemer; Janel Long-Boyle
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.